Published in Pathol Biol (Paris) on January 01, 1971
Experimental rabbit syphilis. Br J Vener Dis (1971) 1.55
Persisting virulence of T. pallidum after incubation with penicillin in Nelson-Mayer medium. Br J Vener Dis (1972) 0.99
Characterization of MexE-MexF-OprN, a positively regulated multidrug efflux system of Pseudomonas aeruginosa. Mol Microbiol (1997) 5.91
Swarming of Pseudomonas aeruginosa is dependent on cell-to-cell signaling and requires flagella and pili. J Bacteriol (2000) 4.59
Mutations in human TBX3 alter limb, apocrine and genital development in ulnar-mammary syndrome. Nat Genet (1997) 3.91
Determinants of efficacy and toxicity of aminoglycosides. J Antimicrob Chemother (1989) 2.30
Characterization of MexT, the regulator of the MexE-MexF-OprN multidrug efflux system of Pseudomonas aeruginosa. J Bacteriol (1999) 1.96
In-vitro activity of newer quinolones against aerobic bacteria. J Antimicrob Chemother (1986) 1.71
Activity of ten antimicrobial agents against anaerobic bacteria. J Antimicrob Chemother (1978) 1.66
Cellular events and intracellular survival of Campylobacter jejuni during infection of HEp-2 cells. Infect Immun (1989) 1.65
Transport of pefloxacin across the bacterial cytoplasmic membrane in quinolone-susceptible Staphylococcus aureus. Antimicrob Agents Chemother (1992) 1.62
Resistance occurring after fluoroquinolone therapy of experimental Pseudomonas aeruginosa peritonitis. Antimicrob Agents Chemother (1987) 1.62
In vitro effects of four macrolides (roxithromycin, spiramycin, azithromycin [CP-62,993], and A-56268) on Toxoplasma gondii. Antimicrob Agents Chemother (1988) 1.61
Role of TNF and IL-1 in infections with Toxoplasma gondii. Immunology (1990) 1.61
A plasmid-mediated cephalosporinase from Achromobacter species. J Infect Dis (1982) 1.55
Experimental rabbit syphilis. Br J Vener Dis (1971) 1.55
Contribution of beta-lactamase hydrolysis and outer membrane permeability to ceftriaxone resistance in Enterobacter cloacae. Antimicrob Agents Chemother (1987) 1.55
Treatment of vascular graft infection by in situ replacement with a rifampin-bonded gelatin-sealed Dacron graft. J Vasc Surg (1994) 1.51
Interstitial deletion of the long arm of chromosome 3 in a patient with mental retardation and congenital anomalies. Hum Genet (1983) 1.45
Expression of host resistance to Salmonella typhi and Salmonella typhimurium: bacterial survival within macrophages of murine and human origin. Microb Pathog (1990) 1.42
Biochemical changes in phytohemagglutinin stimulated human lymphocytes. Exp Cell Res (1966) 1.39
Effect of motility and chemotaxis on the invasion of Salmonella typhimurium into HeLa cells. Microb Pathog (1990) 1.38
Antibiotic efflux pumps in prokaryotic cells: occurrence, impact on resistance and strategies for the future of antimicrobial therapy. J Antimicrob Chemother (2003) 1.33
Pan-European survey of patients' attitudes to antibiotics and antibiotic use. J Int Med Res (1996) 1.33
Identification of Campylobacter jejuni surface proteins that bind to Eucaryotic cells in vitro. Infect Immun (1990) 1.32
Combination therapy: a way to limit emergence of resistance? Am J Med (1986) 1.30
Feeblemindedness and XXXX karyotype. J Ment Defic Res (1968) 1.30
Role of protein D2 and lipopolysaccharide in diffusion of quinolones through the outer membrane of Pseudomonas aeruginosa. Antimicrob Agents Chemother (1991) 1.24
Influence of previous exposure to antibiotic therapy on the susceptibility pattern of Pseudomonas aeruginosa bacteremic isolates. Clin Infect Dis (2001) 1.22
Reevaluation of the factors involved in the efficacy of new beta-lactams against Enterobacter cloacae. Antimicrob Agents Chemother (1991) 1.16
Novel resistance to imipenem associated with an altered PBP-4 in a Pseudomonas aeruginosa clinical isolate. J Antimicrob Chemother (1990) 1.13
Activity of A-56268 (TE-031), a new macrolide, against Toxoplasma gondii in mice. J Antimicrob Chemother (1988) 1.12
In vitro effects of three new 1,2,4-trioxanes (pentatroxane, thiahexatroxane, and hexatroxanone) on Toxoplasma gondii. Antimicrob Agents Chemother (1989) 1.10
Novel method for measurement of outer membrane permeability to new beta-lactams in intact Enterobacter cloacae cells. Antimicrob Agents Chemother (1991) 1.06
[Main radiological signs of the 4p- syndrome]. Ann Radiol (Paris) (1971) 1.06
The effect of phytohaemagglutinin on the metabolism and gamma-globulin synthesis of human lymphocytes. Biochim Biophys Acta (1966) 1.05
Interstitial deletion of the long arm of chromosome 7 46,XX,del(7)(pter leads to q2200::q3200 leads to qter). Hum Genet (1978) 1.05
Effect of mucin on Campylobacter jejuni association and invasion on HEp-2 cells. Microb Pathog (1988) 1.05
Development of beta-lactam-resistant Enterobacter cloacae in mice. J Infect Dis (1987) 1.04
[Results of inoculation of rabbits from biopsies of primo-secondary syphilitic lesions taken from untreated patients]. Ann Dermatol Syphiligr (Paris) (1968) 1.03
Activity of epiroprim (Ro 11-8958), a dihydrofolate reductase inhibitor, alone and in combination with dapsone against Toxoplasma gondii. Antimicrob Agents Chemother (1994) 1.02
A family with three sibs carrying trisomy 21. Ann Genet (1975) 1.02
Recessive spondylocostal dysostosis: two new cases. Clin Genet (1978) 1.01
Persisting virulence of T. pallidum after incubation with penicillin in Nelson-Mayer medium. Br J Vener Dis (1972) 0.99
X/Y translocation in a family with X-linked ichthyosis, chondrodysplasia punctata, and mental retardation: DNA analysis reveals deletion of the steroid sulphatase gene and translocation of its Y pseudogene. Clin Genet (1988) 0.99
In vitro and in vivo effects of doxycycline on Toxoplasma gondii. Antimicrob Agents Chemother (1990) 0.98
The autosomal recessive form of spondylocostal dysostosis. Radiology (1974) 0.98
C-terminal region of Pseudomonas aeruginosa outer membrane porin OprD modulates susceptibility to meropenem. Antimicrob Agents Chemother (2001) 0.97
The Coffin-Siris syndrome in two siblings. Pediatr Radiol (1986) 0.97
Distinctive hair changes (pili torti) in Rapp-Hodgkin ectodermal dysplasia syndrome. Clin Genet (1982) 0.96
Extra band in the 9qh+ chromosome in a normal father and in his child with multiple congenital anomalies. Hum Genet (1982) 0.96
Syphilis in 1986. J Clin Neuroophthalmol (1987) 0.96
Activity of minocycline against Toxoplasma gondii infection in mice. J Antimicrob Chemother (1991) 0.96
Bacterial antibiotic efflux systems of medical importance. Cell Mol Life Sci (1999) 0.95
Synergistic effect of quinolones and oxacillin on methicillin-resistant Staphylococcus species. Antimicrob Agents Chemother (1989) 0.95
Fish oil decreases natural resistance of mice to infection with Salmonella typhimurium. Metabolism (1992) 0.95
Hydrolysis of Cefotaxime by a beta-lactamase from Bacteroides fragilis. Antimicrob Agents Chemother (1980) 0.94
Oro-facial-digital syndrome II. Transitional type between the Mohr and the Majewski syndromes: report of two new cases. Clin Genet (1987) 0.94
Genetic background of attenuated Salmonella typhimurium has profound influence on infection and cytokine patterns in human dendritic cells. J Leukoc Biol (2001) 0.94
Partial deletion of the short arm of chromosome 20: 46,XX,del(20)(p11)/46,XX mosaicism. Clin Genet (1988) 0.94
Interstitial deletion of chromosome 1 (q23-q25). Report of a case. Clin Genet (1984) 0.93
Respective role of polymorphonuclear leukocytes and their integrins (CD-11/18) in the local or systemic toxicity of lipopolysaccharide. J Leukoc Biol (1993) 0.93
Radiological features in trisomy 8. Pediatr Radiol (1979) 0.91
Comparative study of the beta-lactamase activity found in Achromobacter. Can J Microbiol (1983) 0.91
Arteether, a qinghaosu derivative, in toxoplasmosis. Trans R Soc Trop Med Hyg (1988) 0.91
Clinical pharmacokinetics of sisomicin: dosage schedules in renal-impaired patients. Antimicrob Agents Chemother (1976) 0.90
Macrophage oxidative metabolism and intracellular Toxoplasma gondii. Microb Pathog (1989) 0.90
Prevention of vascular graft infection by rifampin bonding to a gelatin-sealed Dacron graft. Ann Vasc Surg (1991) 0.90
Prenatal diagnosis of lethal multiple pterygium syndrome in mid-pregnancy. Ultrasound Obstet Gynecol (1998) 0.89
Newly documented antimicrobial activity of quinolones. Eur J Clin Microbiol Infect Dis (1991) 0.89
Effects of ampicillin, ceftriaxone, chloramphenicol, pefloxacin and trimethoprim-sulphamethoxazole on Salmonella typhi within human monocyte-derived macrophages. J Antimicrob Chemother (1990) 0.89
[Trial therapy of psoriasis with azathioprine]. Bull Soc Fr Dermatol Syphiligr (1970) 0.89
Comparative pharmacokinetics and metabolism of levetiracetam, a new anti-epileptic agent, in mouse, rat, rabbit and dog. Xenobiotica (2004) 0.88
Interstitial deletion of the long arm of chromosome 2 (q31q33) in a girl with multiple anomalies and mental retardation. Hum Genet (1983) 0.88
Emergence of resistance after therapy with antibiotics used alone or combined in a murine model. J Antimicrob Chemother (1986) 0.87
In an elite cross of maize a major quantitative trait locus controls one-fourth of the genetic variation for grain yield. Theor Appl Genet (1995) 0.87
In vitro stepwise selection of resistance to quinolones, beta-lactams and amikacin in nosocomial gram-negative bacilli. Infection (1994) 0.87
Usual and unusual antibacterial effects of quinolones. J Antimicrob Chemother (1990) 0.86
[Parallel studies on modifications of the behavior of Reiter's treponema (in vitro) and Treponema pallidum (in vivo)]. Pathol Biol (1967) 0.85
Effect of a single dose of cefotaxime or ceftriaxone on human faecal flora. A double-blind study. Drugs (1988) 0.85
Distinctive skeletal dysplasia in Cockayne syndrome. Pediatr Radiol (1986) 0.85
Trends in HIV infection among sexually transmitted disease patients in Paris. AIDS (1996) 0.84
Laboratory survey of fluoroquinolone activity. Rev Infect Dis (1989) 0.83
[Evolution of gentamicin sensitivity in acute postpartum staphylococcal endocarditis]. Ann Med Interne (Paris) (1972) 0.83
[Early malignant syphilis with a fatal course (anatomic examination)]. Bull Soc Fr Dermatol Syphiligr (1970) 0.83
Activity of spiramycin against Toxoplasma gondii in vitro, in experimental infections and in human infection. J Antimicrob Chemother (1988) 0.83
Pierre Robin syndrome with hyperphalangism-clinodactylysm of the index finger: a possible new palato-digital syndrome. Pediatr Radiol (1977) 0.83
Efficacy of different dosing schedules of tobramycin for treating a murine Klebsiella pneumoniae bronchopneumonia. J Antimicrob Chemother (1987) 0.83
Monozygotic twinning and Wiedemann-Beckwith syndrome. Am J Med Genet (1993) 0.83
[Current status of research on the persistence of treponema in tardily treated syphilis]. Prophyl Sanit Morale (1966) 0.83
Arthrogryposis, renal tubular dysfunction, cholestasis, ichthyosis syndrome (ARCI) Eur J Pediatr (1997) 0.83
Postantibiotic effect and host-bacteria interactions. J Antimicrob Chemother (1995) 0.82
Overexpression, refolding, and purification of the histidine-tagged outer membrane efflux protein OprM of Pseudomonas aeruginosa. Protein Expr Purif (2001) 0.82
HIV-1 seroprevalence in patients presenting with sexually transmitted disease (STD): results from six Parisian STD clinics. AIDS (1991) 0.81
Treatment of vascular graft infection by in situ replacement with cryopreserved aortic allografts: an experimental study. J Vasc Surg (1998) 0.81
Salmonella typhimurium thyA mutants fail to grow intracellularly in vitro and are attenuated in mice. Microbiology (2001) 0.80
Anaerobic bacteria: evaluation of disc susceptibility to four cephalosporins. Infection (1978) 0.80
In vitro evaluation of potential drug interactions with levetiracetam, a new antiepileptic agent. Drug Metab Dispos (1999) 0.80
In-vitro toxoplasmacidal activity of cationic electron carriers. J Antimicrob Chemother (1989) 0.80
[Kala-azar in immunosuppressed patients. Apropos of a case disclosed by skin lesions]. Presse Med (1984) 0.80